{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:32Z","timestamp":1772120012296,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014126","name":"GE Global Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To determine the role of whole-body dynamic (WBD)\/Patlak parametric\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose (FDG) positron emission tomography\/computed tomography (PET\/CT) in patients with alveolar echinococcosis (AE). This technique allows separating metabolized from unmetabolized FDG in the blood pool and tissue, potentially providing complementary qualitative information and superior quantification to standard static PET\/CT images.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively analyzed 20 PET\/CT datasets performed for staging or therapy monitoring in patients with confirmed AE. Dynamic and standard static PET\/CT datasets were acquired in all patients, and quantitative imaging parameters were measured in the lesion with the highest uptake (i.e., maximum standardized uptake value (SUVmax) and Patlak parameters) and compared to normal liver tissue (SUVratio and Patlak ratio).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean SUVmax in AE manifestations was 5.7\u2009\u00b1\u20093.1 (3.2\u201313.9), compared to 3.2\u2009\u00b1\u20090.4 (2.5\u20134.2) in non-infected liver tissue, respective values for Patlak were 13.0\u2009\u00b1\u20098.6 (2.7\u201335.5) and 4.9\u2009\u00b1\u20092.8 (0.6\u201312.1). SUVratio (1.8\u2009\u00b1\u20091.1; 1.0\u20135.2) was significantly lower (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) than Patlak ratio (3.2\u2009\u00b1\u20093.2; 1.1\u201315.6). Both ratios correlated significantly with\n                      <jats:italic>E. granulosus<\/jats:italic>\n                      hydatid fluid (EgHF) antibodies (SUVratio\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.73,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; Patlak ratio\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.85,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>WBD PET\/CT yields higher lesion-to-background contrast and may, therefore, have the potential to increase sensitivity in the assessment of hepatic AE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12149-025-02113-9","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:54:10Z","timestamp":1759740850000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole-body dynamic FDG-PET\/CT parametric imaging in alveolar echinococcosis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-0818","authenticated-orcid":false,"given":"Lars","family":"Husmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert-Ram","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotis","family":"Kotasidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula Meyer","family":"zu Schwabedissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Deibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"Huellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2113_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/CMR.17.1.107-135.2004","volume":"17","author":"J Eckert","year":"2004","unstructured":"Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107\u201335.","journal-title":"Clin Microbiol Rev"},{"key":"2113_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2009.11.001","volume":"114","author":"E Brunetti","year":"2010","unstructured":"Brunetti E, Kern P, Vuitton DA, Writing Panel for the W-I. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1\u201316.","journal-title":"Acta Trop"},{"key":"2113_CR3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00268-016-3813-6","volume":"41","author":"A Hillenbrand","year":"2017","unstructured":"Hillenbrand A, Gruener B, Kratzer W, Kern P, Graeter T, Barth TF, et al. Impact of safe distance on long-term outcome after surgical therapy of alveolar echinococcosis. World J Surg. 2017;41:1012\u20138.","journal-title":"World J Surg"},{"key":"2113_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jhep.2008.03.023","volume":"49","author":"PR Torgerson","year":"2008","unstructured":"Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, et al. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008;49:72\u20137.","journal-title":"J Hepatol"},{"key":"2113_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4269\/ajtmh.1990.43.506","volume":"43","author":"RW Ammann","year":"1990","unstructured":"Ammann RW, Hirsbrunner R, Cotting J, Steiger U, Jacquier P, Eckert J. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg. 1990;43:506\u201315.","journal-title":"Am J Trop Med Hyg"},{"key":"2113_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/clinids\/15.2.234","volume":"15","author":"JF Wilson","year":"1992","unstructured":"Wilson JF, Rausch RL, McMahon BJ, Schantz PM. Parasiticidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. Clin Infect Dis. 1992;15:234\u201349.","journal-title":"Clin Infect Dis"},{"key":"2113_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0168-8278(98)80129-3","volume":"29","author":"RW Ammann","year":"1998","unstructured":"Ammann RW, Fleiner-Hoffmann A, Grimm F, Eckert J. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol. 1998;29:994\u20138.","journal-title":"J Hepatol"},{"key":"2113_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/hep.510250305","volume":"25","author":"H Ishizu","year":"1997","unstructured":"Ishizu H, Uchino J, Sato N, Aoki S, Suzuki K, Kuribayashi H. Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology. 1997;25:528\u201331.","journal-title":"Hepatology"},{"key":"2113_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/hep.1840190328","volume":"19","author":"RW Ammann","year":"1994","unstructured":"Ammann RW, Ilitsch N, Marincek B, Freiburghaus AU, Swiss Echinococcosis Study Group. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Hepatology. 1994;19:735\u201342.","journal-title":"Hepatology"},{"key":"2113_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jhep.2004.06.015","volume":"41","author":"RW Ammann","year":"2004","unstructured":"Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976\u20132001). J Hepatol. 2004;41:551\u20139.","journal-title":"J Hepatol"},{"key":"2113_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003964","volume":"9","author":"RW Ammann","year":"2015","unstructured":"Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, et al. Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable alveolar echinococcosis with negative FDG-PET\/CT and anti-EmII\/3-10 serology. PLoS Negl Trop Dis. 2015;9:e0003964.","journal-title":"PLoS Negl Trop Dis"},{"key":"2113_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/hep.20078","volume":"39","author":"S Reuter","year":"2004","unstructured":"Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509\u201317.","journal-title":"Hepatology"},{"key":"2113_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2967\/jnumed.112.109942","volume":"54","author":"C Caoduro","year":"2013","unstructured":"Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013;54:358\u201363.","journal-title":"J Nucl Med"},{"key":"2113_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2113_CR15","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1088\/0031-9155\/58\/20\/7391","volume":"58","author":"NA Karakatsanis","year":"2013","unstructured":"Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A. Dynamic whole-body PET parametric imaging: I. concept, acquisition protocol optimization and clinical application. Phys Med Biol. 2013;58:7391\u2013418.","journal-title":"Phys Med Biol"},{"key":"2113_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/RLU.0000000000004878","volume":"48","author":"A Maurer","year":"2023","unstructured":"Maurer A, Kotasidis F, Deibel A, Burger IA, Huellner MW. Whole-body 18 F-FDG PET\/CT patlak parametric imaging of hepatic alveolar echinococcosis. Clin Nucl Med. 2023;48:1089\u201390.","journal-title":"Clin Nucl Med"},{"key":"2113_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2967\/jnumed.122.264106","volume":"64","author":"F Ricard","year":"2023","unstructured":"Ricard F, Cheson B, Barrington S, Trotman J, Schmid A, Brueggenwerth G, et al. Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the PRoLoG consensus initiative (part 1-clinical). J Nucl Med. 2023;64:102\u20138.","journal-title":"J Nucl Med"},{"issue":"Suppl","key":"2113_CR18","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1016\/j.parint.2005.11.041","volume":"55","author":"P Kern","year":"2006","unstructured":"Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int. 2006;55(Suppl):S283\u20137.","journal-title":"Parasitol Int"},{"key":"2113_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QCO.0b013e32833d7516","volume":"23","author":"P Kern","year":"2010","unstructured":"Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis. 2010;23:505\u201312.","journal-title":"Curr Opin Infect Dis"},{"key":"2113_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4269\/ajtmh.2008.79.301","volume":"79","author":"T Junghanss","year":"2008","unstructured":"Junghanss T, da Silva AM, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. 2008;79:301\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"2113_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11050518","author":"PA Kronenberg","year":"2022","unstructured":"Kronenberg PA, Deibel A, Gottstein B, Grimm F, Mullhaupt B, Meyer Zu Schwabedissen C, et al. Serological assays for alveolar and cystic echinococcosis-a comparative multi-test study in Switzerland and Kyrgyzstan. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11050518.","journal-title":"Pathogens"},{"key":"2113_CR22","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1038\/s41598-022-15641-5","volume":"12","author":"L Husmann","year":"2022","unstructured":"Husmann L, Gruenig H, Reiner CS, Deibel A, Ledergerber B, Liberini V, et al. Prediction of benzimidazole therapy duration with PET\/CT in inoperable patients with alveolar echinococcosis. Sci Rep. 2022;12:11392.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"2113_CR23","first-page":"117","volume":"28","author":"I Akira","year":"1997","unstructured":"Akira I. Serodiagnosis of alveolar echinococcosis: detection of antibody against EM18 in patients and rodents. Southeast Asian J Trop Med Public Health. 1997;28(Suppl 1):117\u201324.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2113_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1128\/CVI.00026-10","volume":"17","author":"D Tappe","year":"2010","unstructured":"Tappe D, Sako Y, Itoh S, Frosch M, Gruner B, Kern P, et al. Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clin Vaccine Immunol. 2010;17:944\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"2113_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2021.102356","volume":"83","author":"L Husmann","year":"2021","unstructured":"Husmann L, Muehlematter UJ, Grimm F, Ledergerber B, Messerli M, Kudura K, et al. PET\/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis. Parasitol Int. 2021;83:102356.","journal-title":"Parasitol Int"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02113-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:20:13Z","timestamp":1771586413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02113-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6907316\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}